Common Contracts
15 similar Warrant Agreement contracts by BriaCell Therapeutics Corp., Wetouch Technology Inc., DelMar Pharmaceuticals, Inc., Clean Energy Technologies, Inc.
Form of Representative’s Warrant Agreement WARRANT TO PURCHASE COMMON SHARES BRIACELL THERAPEUTICS CORP.Warrant Agreement • April 28th, 2025 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 28, 2025, (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Form of Representative’s Warrant Agreement WARRANT TO PURCHASE COMMON SHARES BRIACELL THERAPEUTICS CORP.Warrant Agreement • April 22nd, 2025 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ____, 2025 [CLOSING DATE], (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Form of Representative’s Warrant Agreement WARRANT TO PURCHASE COMMON SHARES BRIACELL THERAPEUTICS CORP.Warrant Agreement • April 22nd, 2025 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ____, 2025 [CLOSING DATE], (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Representative’s Warrant Agreement WARRANT TO PURCHASE COMMON SHARES BRIACELL THERAPEUTICS CORP.Warrant Agreement • December 13th, 2024 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December 13, 2024 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BriaCell Therapeutics Corp., a British Columbia corporation (the “Company”), up to ______ Common Shares, without par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • February 23rd, 2024 • Wetouch Technology Inc. • Computer peripheral equipment, nec • New York
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Wetouch Technology Inc., a Nevada company (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, WestPark Capital, Inc. and Craft Capital Management LLC, as representatives (the “Representatives”), dated February 20, 2024 (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from August 18, 2024 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on February 18, 2029 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the Company (as
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • September 22nd, 2023 • Wetouch Technology Inc. • Computer peripheral equipment, nec • New York
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Wetouch Technology Inc., a Nevada company (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, WestPark Capital, Inc. and Craft Capital Management LLC, as representatives (the “Representatives”), dated _________, 2023, as amended (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from________, 2024 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on ___________, 2028 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the Comp
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • March 21st, 2023 • Wetouch Technology Inc. • Computer peripheral equipment, nec • New York
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Wetouch Technology Inc., a Nevada company (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, Craft Capital Management LLC and R.F. Lafferty & Co. Inc., as representatives (the “Representatives”), dated _________, 2023, as amended (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from________, 2023 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on ___________, 2027 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the Co
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • January 31st, 2023 • Clean Energy Technologies, Inc. • Motors & generators
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Clean Energy Technologies, Inc., a Nevada corporation (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, Craft Capital Management, LLC and R.F. Lafferty & Co. Inc., as representatives (the “Representatives”), dated _________, 2023 (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from________, 2023 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the Offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on ___________, 2028 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the C
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • January 28th, 2022 • Wetouch Technology Inc. • Computer peripheral equipment, nec • New York
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Wetouch Technology Inc., a Nevada company (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, Craft Capital Management LLC and R.F. Lafferty & Co. Inc., as representatives (the “Representatives”), dated _________, 2022, as amended (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from________, 2022 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on ___________, 2027 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the Co
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • December 23rd, 2021 • Wetouch Technology Inc. • Computer peripheral equipment, nec • New York
THIS REPRESENTATIVE WARRANT (this “Warrant”) certifies that, pursuant to that certain Underwriting Agreement by and among Wetouch Technology Inc., a Nevada company (the “Company”) and, on behalf of the Underwriters named on Schedule I thereto, Craft Capital Management LLC and R.F. Lafferty & Co. Inc., as representatives (the “Representatives”), dated _________, 2022, as amended (the “Underwriting Agreement”), __________(“Holder”) and its assignees, as registered holders of this Warrant, is entitled, at any time or from time to time from________, 2022 (the “Exercise Date”), the date that is one hundred eighty (180) days after the commencement of sales of the offering pursuant to which this Warrant is being issued, and at or before 5:00 p.m., Eastern time, on ___________, 2027 (fifty-four (54) month anniversary of the Exercise Date) (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ____________ shares of Common Stock of the Co
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • September 18th, 2020 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • March 13th, 2020 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR...Warrant Agreement • November 27th, 2019 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
THIS WARRANT IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].
COMMON STOCK PURCHASE WARRANT DELMAR PHARMACEUTICALS, INC.Warrant Agreement • August 15th, 2019 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is 180 days from the effective date (“Effective Date”) of the Registration Statement as defined below (the “Initial Exercise Date”) and on or prior to the close of business on [ ], 20221 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT DELMAR PHARMACEUTICALS, INC.Warrant Agreement • August 12th, 2019 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is 180 days from the effective date (“Effective Date”) of the Registration Statement as defined below (the “Initial Exercise Date”) and on or prior to the close of business on [ ], 20221 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).